Purpose: Infection with Helicobacter pylori is an important risk factor for gastric cancer in humans. We compared the clinicopathologic features of gastric cancer patients based on H. pylori infection. Materials and Methods: We prospectively studied 155 patients who had gastric cancer and underwent gastrectomies in 1 hospital in Korea. We examined H. pylori infections using the rapid urease test (RUT) with gastrectomy specimens and collected clinical and pathologic data. Results: The number of H. pylori infections based on the RUT was 137 (88%). The H. pylori-negative group was significantly associated with AGC and tumor histology. H. pylori infection was significantly correlated with type I/IIa in EGC and type III/IV/V in AGC. AGC was significantly correlated with larger tumor size, lymphatic invasion, perineural invasion, and H. pylori infection based on univariate and multivariate analyses. Conclusions: We report the prevalence of H. pylori based on the RUT in gastric cancer patients. H. pylori infection influences the tumor histology, progression, and growth type of gastric cancer.
Introduction
Helicobacter was discovered in 1983,(1) but it was not until 1989 that it was suggested that H. pylori plays a role in the development of precancerous lesions.(2) Further, it has been suggested that H. pylori is associated with gastric cancer based on the findings that H. pylori is more prevalent in patients with atrophic gastritis than a control group. were assessed by questionnaire, and patients with a past history of infection were excluded.
Materials and Methods
In the current study, the status of H. pylori infection was assessed by the RUT. As we reported previously, (10) A P-value＜0.05 was considered to be statistically significant. 
Results
Among 155 patients, 99 were male, 56 were female, and the mean age was 61.6 and 58.1 years, respectively. Ninety-seven patients were ＞60 years of age and 58 patients were ＜60 years of age. One hundred thirty-seven patients were H. pylori-positive based on the RUT test, for an 88.4% infection rate.
The clinicopathologic factors of H. pylori-positive and -negative gastric cancer patients were compared (Table 1 ). In the H. pylori-negative group, AGC was prevalent (P=0.021), The patients were divided into EGC (74 patients) and AGC groups (81 patients) ( 
Discussion
In a nested-case control study conducted in many countries, the rate of H. pylori infection in the gastric cancer and control groups was reported to be 81.2% and 66.1%, respectively.(13) In a Japanese study, the infection rate in the gastric cancer and control groups was reported to be 91.1% and 75.6%, respectively. (14) In a prospective study, gastric cancer patients existed in the H. pyloripositive group only, and the infection rate in the gastric cancer group was shown to be 100%. (15) In a nested-case control study conducted in Korea, the status of H. pylori infection in gastric cancer patients was examined, and 83.7% patients were positive. (16) This was not greatly different from the results of the current study (88.4%) that measured the rate of H. pylori infection by RUT only.
In the current study, analyzed according to age and gender, the rate of H. pylori infection did not show a significant difference, and other cinical factors also did not show significant differences. In the current study, the status of H. pylori infection was determined by the results of the RUT only. In comparison with the status of H.
pylori infection assessed by serological tests, a significant difference was not shown. In the 155 patients, the positive prediction rate by the RUT was shown to be high, but a significant difference was not shown, which may may be due to patients in whom the serological tests were false-negative, false-positive RUT, or harvested specimens that were H. pylori-positive, but H. pylori was absent. Since each study assessed the infection rate of H. pylori using different methods, a direct comparison was difficult. Parsonnet et al. (20) reported that gastric cancer was classified into intestinal-and diffuse-type gastric cancer and found that in the H. pylori infection group, intestinal-type gastric cancer was significantly more abundant. In the current study, the association between H. pylori infection and the diffuse-type gastric cancer was not significantly different from the intestinal-type gastric cancer classified according to the Lauren's classification. In the current study, when gastric cancer was classified by histologic morphology according to the WHO classification, a significant difference between the two groups was shown. The poorly undifferentiated tubular-and mucious-type in the negative group was 38.9% (7/18) and 16.7% (3/18), respectively, and it was shown to be relatively more prevalent. Interestingly, 100% signet ring cell-type was detected in the H. pylori-positive group, and such results could be considered in connection to the high incidence of the signet celltype in Korean patients with gastric cancer. (21) Tatsuta et al. (22) reported that H. pylori infection was significantly more abundant in well-differentiated tumors in patients with EGC. In the current study, the WHO classification was broadly divided into the differentiation group (papillary-, well differentiated-, and moderately differentiated tubular-type) and the undifferentiated group (poorly differentiated tubular-, mucinous-, and the signet ring cell-type) and compared; such a difference was not detected.
The signet cell-type occurs only in the H. pylori-positive group.
Therefore, such results are in agreement with the theory that H.
pylori infection is associated with the development of the intestinaltype gastric cancer, as shown previously, and it also shows that H.
pylori infection is closely associated with the development of signet cell-type gastric cancer. Thus, it suggests that H. pylori infection could exert effects on the phenotype of gastric cancer cells.
In a meta-analysis that compared EGC with AGC, AGC was significantly more prevalent in the H. pylori-negative group in comparison with EGC,(5) and our results were similar. In the current study, when EGC was examined according to morphology, in the H. pylori-negative group, 3 cases were the elevated shape (I/ IIa) and 1 case was the flat/depressed shape (IIb/IIc/III), and the H. pylori-positive group 13 of 70 cases had the elevated shape, thus the elevated shape was more prevalent.
In a study analyzed EGC according to H. pylori infection, the infection rate was significantly low in depressed-type EGC, including ulcers. (22) In the current study, in the H. pylori-positive group, type IIc EGC was most prevalent, followed by type IIb, IIa, I, and III in order. In the negative group, the order was IIa＞I=IIc.
Nonetheless, in the current study, the association of H. pylori infection with the depressed-type EGC was examined and significant results were not shown. In the current study, the number of the H.
pylori-negative group, as well as the depressed-type was detected, and patients who had an indication for endoscopic submucosal dissection were excluded, and thus it is difficult to compare directly with the extant literatures.
The ratio of H. pylori infection in EGC and AGC was described pylori could not survive, and such a hypothesis could be applicable to Borrmann type IV gastric cancer infiltrating the entire stomach.
Second, it could be hypothesized that H. pylori infection itself mediates effects on the progression of gastric cancer, and thus in H.
pylori-positive gastric cancer, the progression is slow; however, in H. pylori-negative gastric cancer, rapid progression was shown and thus the ratio of advanced gastric cancer becomes high, and the biological characteristic of gastric cancer may be aggressive. This concurs well to the fact that the prognosis of H. pylori-negative patients is poor. (24) In addition, it was observed that in Borrmann type I and II gastric cancer, the rate of the H. pylori-positive rate was high, which shows the close association of the relatively slow progression with H. pylori infection.
H. pylori is a carcinogenic factor for gastric cancer, and depending on the infection status, differences of the frequency of EGC from AGC were shown, and differences of the growth pattern between AGC and EGC were shown. In the histologic classification, differences were also shown, and thus it appears that the status of H. pylori infection exerts effects on the development of gastric cancer and the progression pattern. Nonetheless, the rate of H. pylori infection is high in Korea, consequently, the number of the control group in the current study was small, and thus significant differences were not detected in several categories. In the current study, the status of H. pylori infection according to serological and RUT tests showed great differences, and thus it is thought that studies on the method of the diagnosis of H. pylori infection is required. If more studies are conducted, the clinical course, as well as the pattern of progression of gastric cancer according to H. pylori infection, could be better elucidated.
